Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway
Abstract Object Bufei Yishen formula (BYF), a traditional Chinese medicine alleviates COPD symptoms and suppresses airway epithelial inflammation. In this study, we determined whether BYF protects the airway epithelial barrier from destruction in COPD rats. Methods The protective effects of BYF on t...
Main Authors: | Lidan Jia, Xuefang Liu, Xinguang Liu, Qingzhou Guan, Yange Tian, Jiansheng Li, Peng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Chinese Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13020-024-00905-1 |
Similar Items
-
Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
by: Wang W, et al.
Published: (2023-04-01) -
The Evaluation of Effective-component Compatibility of Bufei Yishen FormulaⅢ and Components Compatibility in Treating Airway Remodeling of COPD
by: QIN Yanqin, DONG Haoran, YANG Jingfan, LI Haibo, ZHAO Peng, LI Jiansheng
Published: (2024-11-01) -
Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
by: Peng Zhao, et al.
Published: (2020-08-01) -
Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway
by: Min-yan Li, et al.
Published: (2022-11-01) -
Effective-Component Compatibility of Bufei Yishen Formula (ECC-BYF) III Inhibits Mucus Hypersecretion by BEAS-2B Cells via miR-146a-5p-Mediated Regulation of the EGFR/MEK/ERK Pathway
by: Wei Y, et al.
Published: (2025-03-01)